Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma
×
tislelizumab
×
Clear all
Filters
3
NCT04363801
2025-10-09
DisTinGuish
Leap Therapeutics, Inc.
Phase 2
Terminated
247 enrolled
38 charts